People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | — | Pharmaceuticals | Pre-Seed | $100K | $4.7M | 2017 |
Allen Baharaff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Allen Baharaff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Sidransky | 1 | 7 |
| Chaim Hurvitz | 1 | 6 |
| Carol Brosgart | 1 | 3 |
| Tali Yaron-Eldar | 1 | 2 |
| Tali Gorfine | 1 | 1 |
| Yohai Stenzler | 1 | 1 |
| Liat Hayardeny | 1 | 1 |
| Shmuel Nir | 1 | 1 |
| William Marth | 1 | 1 |
| Ran Oren | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.